Dr. Clements is recognized as an expert in diabetes data analytics with broad patient care and clinical research experience. He earned his Bachelor of Science degree in Biology and Chemistry (1993) at Butler University, Indianapolis, IN. Following, Dr. Clements earned his Medical Degree (2003) and PhD in Developmental Neuroscience (2003) at Washington University, St. Louis, MO. His previous training in the Medical Scientist Training Program at Washington University School of Medicine provided a strong foundation in basic science research. Dr. Clements trained as a clinical researcher at Children’s Mercy Hospital, where he has applied his skills to clinical trials of new diabetes treatments, clinical trials of treatments designed to prevent type 1 diabetes, intervention development research and risk prediction/health outcomes research in type 1 diabetes. He is Associate Professor at the University of Missouri-Kansas City. He served as Pediatric Chair of the T1D Exchange Clinic Registry from 2016-2019 and currently serves as data science co-lead for the T1D Exchange Quality Improvement Collaborative. He has a particular interest in the application of predictive analytics, real-time data listening, and digital health therapeutics to positively transform diabetes care.

Diana Ferro is Ph.D. Research Assistant Professor at Children’s Mercy Kansas City in the Rising T1De Alliance, a quality improvement and research initiative to get in front of clinical problems by forecasting them and rapidly test innovative digital and behavioral interventions to improve those outcomes. She has 10+ years of experience in research and development. Dr. Ferro graduated with honors at the University of Munster (Germany) and completed her postdoctoral training at the University of Arizona (USA). Her unique training combines philosophy, ethics, statistics, biology, data science, and medicine.  She believes that a multidisciplinary approach is the key to groundbreaking discoveries. She was selected for the “Junior Research Award” by the Italian Association of Developmental and Comparative Immunobiology for her accomplishments. She is committed to facilitating innovation by combining multiple research fields into a unifying framework that can allow researchers to address complex questions and improve the quality of type 1 diabetes care. In addition, she is passionate about mentoring early-career women in science, encouraging them to overcome the countless obstacles they face during a career in STEM. She works with the Rising Tide Alliance Team to implement predictive analytics, match the right patient to the right intervention, and enable real-time, data-driven decision-making to improve type 1 diabetes outcomes in youth and adults.

Dr. Svetlana Kurklinsky is a Director of Clinical Research at Oklahoma State University-Center for Health Sciences. Where she supervises the operations of all the clinical research. In her role she manages budgets and staff. Her other activities are development of new PIs and protocols. She facilitates the collaboration with The National Center for Wellness & Recovery and formation a collaborative effort with VA for comprehensive research efforts in NE Oklahoma. Dr. Kurklinsky got her BS in Molecular biology and Physiology at University of Belgrade, and PhD in Molecular Neuroscience at Mayo Clinic Graduate School of Biomedical Sciences in Rochester, MN. Dr. Kurklinsky has both basic and clinical research expertise. Her research interest is in biology of Chronic Pain.